← All trials
NCT00705757
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 1, 2008
- Primary completion
- Apr 1, 2011
- Completion date
- Apr 1, 2011
- First posted
- —
- Last posted
- —
- Enrollment
- 89
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- Summa Health SystemLead sponsor
- Summa Health SystemOverall official - principal investigator
- Arlington eye AssociatesOverall official - principal investigator
- Summa Health SystemReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.